Image Source: Goldman Laboratories Liposomal technology offers a fascinating approach that controls the body's cellular structure in the current study of liposomal vs sublingual NAD+ delivery methods
2.1.1.4 Education - Educate families regarding potential adverse effects (e.g., gastrointestinal symptoms), the importance of meal adherence to mitigate nausea, as well as the recognition of signs indicative of gallbladder or pancreatic concerns
Both were placed on FDA Category 2 in September 2023, removed in September 2024 after withdrawn nominations, and reviewed by PCAC in late 2024 with FDA recommending against 503A Bulks inclusion
GLP-1's Next Frontier Since GLP-1 drugs are believed to act on brain regions involved in reward and motivation, they may also have potential in the treatment of substance use disorders, including opioid, alcohol, and nicotine addiction, according to researchers
The combination of medication, nutrition management, and consistent exercise produces outcomes that exceed what any single intervention achieves alone
Molecular Weight: ~850 Da (approx.)
